For permission requests, please contact NEJM Reprints at [email protected] Select the format you want to export the citation of this publication.

Zoledronate prevents fractures in older women when administered ... the protocol (available with the full text of this article at NEJM.org); and the first author wrote the first draft of the ...

Vitamin D supplements have long been touted as offering myriad health benefits, including protecting against cognitive decline, cancer, and bone fractures, and even increasing one’s lifespan. But ...

For early postmenopausal women, zoledronate administered at baseline and 5 years is effective for preventing morphometric vertebral fracture.

Research published in the New England Journal of Medicine reveals the long-term benefits of this bone-strengthening drug in reducing fractures among women in the early stages of menopause.

Women in early menopause treated with zoledronate in just two infusions, 5 years apart, show a significantly reduced risk of sustaining a vertebral fracture ... the New England Journal of Medicine.